Pathogenesis and Significance of Diabetic Dyslipidemia
Authors:
M. Zeman 1; A. Žák 2
Authors‘ workplace:
IV. interní klinika 1. LF UK a VFN, Praha 2Ústav klinické biochemie a laboratorní diagnostiky 1. LF UK a VFN, Praha
1
Published in:
Čas. Lék. čes. 2004; : 302-306
Category:
Overview
Patients with type 2 diabetes mellitus are at the higher risk of development of on arteriosclerosis based cardiovasculardiseases. Epidemiological studies have shown that diabetic dislipidemiawith hypertriglyceridemia, presence of smalldense LDL subfraction, low concentration of HDL-cholesterol and increased postprandial lipemia can representa serious threat. Several studies have found significant decrease of cardiovascular morbidity and mortality aftera treatment of diabetic dislipidemia, namely by statins and fibrates. Contemporary therapeutic algorhithms ofEuropean and American professional societies for the hyperlipidemia treatment classify diabetes mellitus as anequivalent of already developed complication of atherosclerosis. Our article presents pathophysiology of the diabeticdislipidemia, recommended target values of pasma lipids in diabetic patients and an overview of present possibilitiesof pharmacotherapy of the diabetic dislipidemia.
Key words:
diabetic dislipidemia, cardiovascular diseases, statins, fibrates, combination therapy of hypolipidemia,polyenic fatty acids.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Vasopressin and its Analogues in the Therapy of Shock
- Classic Adamantinoma, Differentiated Adamantinoma and OsteofibrousDysplasia of Long Bones
- Complex Therapy of Chronic Hepatic Encephalopathy Completed withProbiotic: Comparison of Two Studies
- Relevance of p53 Protein and itsMutations for Novel Strategies in Cancer Therapy